|
Part I Basic Laboratory Techniques |
|
|
1 | (177) |
|
1 Fundamentals of the Clinical Laboratory |
|
|
1 | (16) |
|
Clinical Laboratory Science |
|
|
2 | (1) |
|
Clinical Laboratory Science as a Profession |
|
|
2 | (1) |
|
Original Credentialing and Professional Organizations |
|
|
3 | (1) |
|
Individual Professional Recognition |
|
|
3 | (1) |
|
Additional Individual Professional Certification and Licensure |
|
|
3 | (1) |
|
|
3 | (1) |
|
Clinical Laboratory Science Program Accreditation |
|
|
4 | (1) |
|
Clinical Laboratory Overview |
|
|
4 | (1) |
|
|
4 | (1) |
|
|
4 | (1) |
|
Clinical Laboratory Improvement Amendments of 1988 |
|
|
5 | (1) |
|
Clinical Laboratory Improvement Amendments Requirements for Personnel |
|
|
5 | (1) |
|
Levels of General Laboratory Testing |
|
|
6 | (1) |
|
|
6 | (1) |
|
Traditional Departments of a Clinical Laboratory |
|
|
6 | (1) |
|
|
7 | (1) |
|
Expanded Directions of Laboratory Testing: Molecular Diagnostics |
|
|
8 | (1) |
|
Health Care Organizations |
|
|
8 | (1) |
|
Primary Accrediting Organizations |
|
|
8 | (1) |
|
Commission on Office Laboratory Accreditation |
|
|
9 | (1) |
|
College of American Pathologists |
|
|
9 | (1) |
|
|
9 | (1) |
|
|
9 | (1) |
|
External Government Laboratory Accreditation and Regulation |
|
|
9 | (1) |
|
Alternate Sites of Testing |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
11 | (1) |
|
Physician Office Laboratories |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
Health Insurance Portability and Accountability Act |
|
|
11 | (1) |
|
New Patient Access Regulations |
|
|
12 | (1) |
|
|
12 | (1) |
|
Other Legal Considerations |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
14 | (3) |
|
2 Safety: Patient and Clinical Laboratory Practices |
|
|
17 | (38) |
|
|
19 | (1) |
|
Joint Commission: Laboratory National Patient Safety Goals |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
19 | (2) |
|
Safety Standards and Governing Agencies |
|
|
21 | (1) |
|
National Healthcare Safety Network |
|
|
21 | (1) |
|
Occupational Safety and Health Administration Acts and Standards |
|
|
22 | (1) |
|
Occupational Safety and Health Administration-Mandated Plans |
|
|
22 | (5) |
|
Threats to Laboratory Safety: Supply Chain Interruption |
|
|
27 | (1) |
|
Avoiding Transmission of Infectious Diseases |
|
|
27 | (1) |
|
Biosafety and Biosafety Levels |
|
|
27 | (2) |
|
Highlights of Sars-Cov-2 Laboratory Biosafety |
|
|
29 | (1) |
|
Laboratory-Acquired Infections |
|
|
30 | (1) |
|
|
30 | (2) |
|
Safe Work Practices for Infection Control |
|
|
32 | (1) |
|
Other Practices Necessary for Safety Assurance |
|
|
32 | (1) |
|
Protective Techniques for Infection Control |
|
|
32 | (1) |
|
Personal Protective Equipment |
|
|
33 | (5) |
|
|
38 | (1) |
|
Decontamination of Work Surfaces, Equipment, and Spills |
|
|
38 | (1) |
|
Guidance for SARS-CoV-2 Decontamination |
|
|
39 | (1) |
|
General Infection Control Safety Practices |
|
|
39 | (2) |
|
Specimen Handling and Shipping Requirements |
|
|
41 | (1) |
|
Final Decontamination of Waste Materials |
|
|
41 | (1) |
|
Prevention of Disease Transmission |
|
|
41 | (1) |
|
|
41 | (2) |
|
|
43 | (1) |
|
|
43 | (1) |
|
Prophylaxis, Medical Follow-Up, and Records of Accidental Exposure |
|
|
44 | (1) |
|
Respirators or Masks for Tuberculosis Control |
|
|
45 | (1) |
|
|
45 | (1) |
|
Additional Laboratory Hazards |
|
|
45 | (1) |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
Final Decontamination of Waste Materials |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
Basic First-Aid Procedures |
|
|
49 | (1) |
|
|
50 | (5) |
|
3 Quality Assessment and Quality Control in the Clinical Laboratory |
|
|
55 | (25) |
|
|
56 | (1) |
|
|
57 | (1) |
|
Clinical Laboratory Improvement Amendments |
|
|
57 | (1) |
|
Voluntary Accrediting Organizations |
|
|
58 | (1) |
|
|
58 | (1) |
|
College of American Pathologists |
|
|
58 | (1) |
|
International Standards for Clinical Laboratories |
|
|
58 | (1) |
|
Lean and Six Sigma Quality Systems |
|
|
59 | (1) |
|
|
59 | (1) |
|
Quality Assessment---Error Analysis |
|
|
60 | (1) |
|
Quality Assessment---Phases of Testing |
|
|
60 | (1) |
|
|
60 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
Accuracy in Reporting Results and Documentation |
|
|
61 | (1) |
|
|
62 | (1) |
|
|
62 | (1) |
|
Quality Assessment Descriptors |
|
|
63 | (1) |
|
Accuracy Versus Precision |
|
|
64 | (1) |
|
Sensitivity and Specificity of a Test |
|
|
64 | (1) |
|
|
65 | (1) |
|
Quality Control Statistics |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
67 | (1) |
|
Determination of Control Range |
|
|
67 | (1) |
|
Sources of Variance or Error |
|
|
68 | (1) |
|
Monitoring Quality Control |
|
|
68 | (1) |
|
|
68 | (2) |
|
|
70 | (1) |
|
|
70 | (1) |
|
Other Quality Control Rules |
|
|
71 | (1) |
|
Nonanalytical Factors in Quality Assessment |
|
|
72 | (2) |
|
|
74 | (1) |
|
|
75 | (1) |
|
|
75 | (5) |
|
|
80 | (17) |
|
|
81 | (1) |
|
|
81 | (1) |
|
|
82 | (1) |
|
|
82 | (2) |
|
|
84 | (2) |
|
|
86 | (1) |
|
Care and Cleaning of the Microscope |
|
|
86 | (1) |
|
Cleaning the Microscope Exterior |
|
|
86 | (1) |
|
|
86 | (1) |
|
|
86 | (1) |
|
|
86 | (1) |
|
|
87 | (1) |
|
Cleaning the Stage and Adjustment Knobs |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
88 | (1) |
|
Other Types of Microscopes (Illumination Systems) |
|
|
88 | (1) |
|
|
88 | (1) |
|
Differential Interference-Contrast Microscope |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
89 | (1) |
|
Phase-Contrast Microscope |
|
|
90 | (2) |
|
Polarized and Compensated Polarized Microscopes |
|
|
92 | (1) |
|
|
92 | (1) |
|
Artificial Neural Networks |
|
|
93 | (1) |
|
Digital Cell Morphology and Workflow |
|
|
94 | (1) |
|
|
94 | (3) |
|
5 Systems of Measurement, Laboratory Equipment, and Reagents |
|
|
97 | (21) |
|
|
98 | (1) |
|
English and Metric Systems |
|
|
99 | (1) |
|
International System (SI System) |
|
|
99 | (1) |
|
|
99 | (2) |
|
|
101 | (1) |
|
Reporting Results in SI Units |
|
|
101 | (1) |
|
|
102 | (1) |
|
|
102 | (1) |
|
|
102 | (3) |
|
|
105 | (2) |
|
Cleaning Laboratory Glassware and Plasticware |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
108 | (1) |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
Technical Factors in Using Centrifuges |
|
|
111 | (1) |
|
Special Precautions for Centrifugation of Blood and Body Fluids |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
112 | (1) |
|
Quality Control and Impurity Testing |
|
|
112 | (1) |
|
|
113 | (1) |
|
Purification of Water Process |
|
|
113 | (1) |
|
Reagents Used in Laboratory Assays |
|
|
114 | (1) |
|
|
114 | (1) |
|
|
114 | (1) |
|
Hazardous Chemicals Communication Policies |
|
|
114 | (1) |
|
|
114 | (1) |
|
|
115 | (1) |
|
Concentration of Solutions |
|
|
115 | (1) |
|
Transfer and Dilution of Chemicals for Reagents |
|
|
115 | (1) |
|
Labeling the Reagent Container |
|
|
115 | (1) |
|
Checking a Reagent Before Use |
|
|
115 | (1) |
|
|
115 | (1) |
|
|
115 | (3) |
|
6 Laboratory Mathematics and Solution Preparation |
|
|
118 | (11) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
Density and Specific Gravity |
|
|
120 | (1) |
|
Expressions of Solution Concentration |
|
|
120 | (1) |
|
Weight (Mass) per Unit Volume |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
121 | (1) |
|
|
121 | (1) |
|
Osmolality and Osmolarity |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
Concentrations of Solutions |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
125 | (1) |
|
|
125 | (4) |
|
7 Basic and Contemporary Techniques in the Clinical Laboratory |
|
|
129 | (26) |
|
|
130 | (1) |
|
Absorbance Spectrophotometry |
|
|
130 | (1) |
|
|
131 | (1) |
|
Beer-Lambert (Beer's) Law |
|
|
132 | (1) |
|
Expressions of Light Transmitted or Absorbed |
|
|
133 | (1) |
|
Preparation and Use of a Standard Curve |
|
|
133 | (2) |
|
Instruments Used in Spectrophotometry |
|
|
135 | (1) |
|
Parts Essential to All Spectrophotometers |
|
|
136 | (1) |
|
|
137 | (1) |
|
Care and Handling of Spectrophotometers |
|
|
137 | (1) |
|
Quality Control Tests for Spectrophotometers |
|
|
137 | (1) |
|
Reflectance Spectrophotometry |
|
|
137 | (1) |
|
Principle and Quality Control |
|
|
138 | (1) |
|
Parts of a Reflectance Spectrophotometer |
|
|
138 | (1) |
|
Applications of Reflectance Spectrophotometry |
|
|
138 | (1) |
|
Fluorescence Spectrophotometry |
|
|
138 | (1) |
|
|
138 | (1) |
|
|
139 | (1) |
|
Optical System and Measurement |
|
|
139 | (1) |
|
Advantages and Disadvantages |
|
|
139 | (1) |
|
|
140 | (1) |
|
Fundamentals of Laser Technology |
|
|
140 | (1) |
|
Principles of Flow Cytometry |
|
|
140 | (1) |
|
|
140 | (2) |
|
|
142 | (1) |
|
Basic Immunofluorescence Labeling Techniques |
|
|
143 | (1) |
|
Alternative Labeling Technologies |
|
|
144 | (1) |
|
Time-Resolved Fluoroimmunoassay |
|
|
144 | (1) |
|
Fluorescence Polarization Immunoassay |
|
|
144 | (1) |
|
Fluorescence In Situ Hybridization |
|
|
144 | (1) |
|
Signal Amplification Technology |
|
|
144 | (1) |
|
Magnetic Labeling Technology |
|
|
144 | (1) |
|
|
144 | (1) |
|
|
144 | (1) |
|
Chromatography and Immunochromatography |
|
|
145 | (1) |
|
Types of Chromatographic Methods |
|
|
145 | (1) |
|
Lateral or Vertical Flow Immunoassays (Immunochromatography) |
|
|
145 | (1) |
|
|
146 | (1) |
|
|
146 | (2) |
|
|
148 | (1) |
|
|
148 | (7) |
|
8 Laboratory Testing: From Point of Care to Total Automation |
|
|
155 | (23) |
|
|
156 | (1) |
|
The Importance of Decentralized Laboratory Point-of-Care Testing Assays |
|
|
156 | (1) |
|
|
156 | (1) |
|
Quality Control and Regulations |
|
|
157 | (1) |
|
|
157 | (1) |
|
Patient-Centric Laboratory Testing |
|
|
158 | (1) |
|
Personal Direct-to-Consumer Genetic Testing |
|
|
158 | (1) |
|
Non--Instrument-Based Point-of-Care Testing |
|
|
158 | (1) |
|
Ultralow-Cost Diagnostics |
|
|
158 | (1) |
|
Nonautomated Point-of-Care Testing |
|
|
159 | (1) |
|
|
160 | (1) |
|
|
161 | (1) |
|
Handheld Point-of-Care Testing Equipment |
|
|
162 | (2) |
|
Emerging Patient-Centric Technologies |
|
|
164 | (1) |
|
|
164 | (1) |
|
|
164 | (1) |
|
|
165 | (1) |
|
What Is a Laboratory Information Management System? |
|
|
165 | (1) |
|
What Is a Laboratory Information System? |
|
|
165 | (2) |
|
|
167 | (1) |
|
Communication and Network Devices |
|
|
168 | (2) |
|
|
170 | (1) |
|
Preanalytical (Pre-Examination) Functions |
|
|
170 | (1) |
|
Analytical (Examination) Functions |
|
|
170 | (1) |
|
Postanalytical (Postexamination) Functions |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
Steps in Automated Analysis |
|
|
172 | (1) |
|
Specimen Collection and Processing |
|
|
172 | (1) |
|
|
173 | (1) |
|
|
174 | (4) |
|
Part II Basic Clinical Laboratory Specializations |
|
|
178 | (31) |
|
9 Phlebotomy: Collecting and Processing Patient Blood Specimens |
|
|
178 | (29) |
|
|
179 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
181 | (1) |
|
|
181 | (1) |
|
|
181 | (1) |
|
|
181 | (1) |
|
Isolation as a Safety System |
|
|
181 | (1) |
|
Standard and Additional Precautions |
|
|
181 | (1) |
|
|
182 | (1) |
|
|
182 | (1) |
|
Blood Collection Variables |
|
|
183 | (1) |
|
Blood Collection Procedures |
|
|
184 | (1) |
|
Layers of Normal Anticoagulated Blood |
|
|
184 | (1) |
|
Environmental Factors Associated With Evacuated Blood Collection Tubes |
|
|
184 | (1) |
|
Expiration Dates of Evacuated Tubes |
|
|
185 | (1) |
|
|
185 | (1) |
|
|
186 | (2) |
|
|
188 | (5) |
|
Venous Blood Collection (Phlebotomy) |
|
|
193 | (1) |
|
|
193 | (1) |
|
Special Blood Collection: Blood Cultures |
|
|
193 | (1) |
|
|
193 | (1) |
|
Special Site-Selection Situations |
|
|
194 | (1) |
|
|
194 | (1) |
|
Venipuncture Complications |
|
|
195 | (1) |
|
Specimens: General Preparation |
|
|
195 | (1) |
|
Processing Blood Specimens |
|
|
195 | (1) |
|
Variations in Specimen Collection and Handling |
|
|
196 | (1) |
|
Unacceptable and Rejected Specimens |
|
|
196 | (1) |
|
Centrifugation of Specimens |
|
|
197 | (1) |
|
Storage of Processed Specimens |
|
|
198 | (1) |
|
|
198 | (1) |
|
Logging and Reporting Processes |
|
|
199 | (1) |
|
Capillary or Peripheral Blood Collection By Skin Puncture |
|
|
199 | (1) |
|
Blood Spot Collection for Neonatal Screening Programs |
|
|
200 | (1) |
|
Capillary Blood for Testing at the Bedside (Point-of-Care Testing) |
|
|
201 | (1) |
|
Capillary Blood Collection |
|
|
201 | (1) |
|
|
201 | (1) |
|
Capillary Blood for Slides |
|
|
201 | (1) |
|
Collecting Microspecimens |
|
|
201 | (1) |
|
|
202 | (1) |
|
|
202 | (5) |
|
10 An Introduction to the Principles and Practice of Clinical Hematology |
|
|
207 | (2) |
|
Part One Hematopoiesis and Cellular Maturation |
|
|
209 | (16) |
|
|
210 | (1) |
|
Erythrocyte Function and Maturation |
|
|
210 | (3) |
|
Hemoglobin Synthesis, Structure, and Function |
|
|
213 | (1) |
|
RBC Formation and Destruction |
|
|
213 | (1) |
|
|
213 | (2) |
|
|
215 | (2) |
|
|
217 | (1) |
|
Variations in Hemoglobin Concentrations |
|
|
218 | (1) |
|
|
218 | (1) |
|
Granulocyte Maturation and Function |
|
|
219 | (1) |
|
|
219 | (3) |
|
Monocyte Maturation and Function |
|
|
222 | (1) |
|
Lymphocyte Maturation and Function |
|
|
222 | (1) |
|
|
223 | (1) |
|
Reporting Leukocyte Results (Total, Relative, and Absolute Counts) |
|
|
224 | (1) |
|
|
225 | (1) |
|
Platelet (Thrombocyte) Maturation and Function |
|
|
225 | (1) |
|
Part Two Hematology Laboratory Assessments |
|
|
225 | (15) |
|
|
225 | (1) |
|
Processing and Testing the Specimen |
|
|
226 | (1) |
|
Osmosis and Osmotic Pressure |
|
|
227 | (1) |
|
Isotonic, Hypotonic, and Hypertonic Solutions |
|
|
227 | (1) |
|
Hemoglobin Measurement in the Laboratory |
|
|
227 | (1) |
|
Hematocrit (Packed Cell Volume) |
|
|
228 | (1) |
|
|
229 | (1) |
|
|
230 | (1) |
|
Mean Corpuscular Hemoglobin |
|
|
230 | (1) |
|
Mean Corpuscular Hemoglobin Concentration |
|
|
230 | (1) |
|
Red Blood Cell Distribution Width |
|
|
231 | (1) |
|
|
231 | (1) |
|
|
231 | (1) |
|
Automated Hematology Instrument Technology |
|
|
232 | (1) |
|
Automated Cell-Counting Methods |
|
|
233 | (3) |
|
Examples of Automated Hematology Technology |
|
|
236 | (2) |
|
Automated Leukocyte Differentiation |
|
|
238 | (1) |
|
Additional Hematology Procedures |
|
|
239 | (1) |
|
|
239 | (1) |
|
Erythrocyte Sedimentation Rate |
|
|
240 | (1) |
|
Part Three Erythrocyte Disorders |
|
|
240 | (12) |
|
Microscopic Examination of a Peripheral blood Film |
|
|
240 | (1) |
|
Sources of Blood for the Blood Film |
|
|
240 | (1) |
|
Microscopic Examination of the Blood Film |
|
|
241 | (6) |
|
|
247 | (2) |
|
Perform the Differential Count of White Cells |
|
|
249 | (1) |
|
|
249 | (3) |
|
|
252 | (1) |
|
|
252 | (1) |
|
Part Four Nonmalignant Leukocyte Disorders |
|
|
252 | (3) |
|
Quantitative Changes in the Total Concentration of Leukocytes |
|
|
253 | (1) |
|
Quantitative Disorders of Granulocytes and Monocytes |
|
|
253 | (1) |
|
Toxic Changes and Granulocyte Alterations |
|
|
253 | (2) |
|
|
255 | (1) |
|
Part Five Malignant Leukocyte Disorders: Leukemias, Lymphoid and Plasma Cell Neoplasms |
|
|
255 | (6) |
|
|
256 | (1) |
|
Acute Myeloid/Myelogenous Leukemia |
|
|
256 | (2) |
|
Acute Lymphoblastic Leukemia |
|
|
258 | (1) |
|
Chronic Myelogenous Leukemia |
|
|
258 | (1) |
|
Chronic Lymphocytic Leukemia |
|
|
259 | (1) |
|
Lymphoid and Plasma Cell Neoplasms |
|
|
260 | (1) |
|
Part Six Other Malignant Hematologic Categories |
|
|
261 | (353) |
|
|
262 | (7) |
|
11 Hemostasis and Blood Coagulation |
|
|
269 | (27) |
|
|
270 | (1) |
|
|
271 | (1) |
|
|
271 | (1) |
|
|
271 | (1) |
|
|
272 | (1) |
|
|
272 | (1) |
|
Quantitative Platelet Disorders |
|
|
272 | (1) |
|
|
272 | (1) |
|
Disorders of Destruction and Utilization of Platelets |
|
|
273 | (1) |
|
Disorders of Platelet Distribution of Platelets |
|
|
273 | (1) |
|
|
273 | (1) |
|
Qualitative Platelet Disorders |
|
|
273 | (1) |
|
|
274 | (1) |
|
|
274 | (1) |
|
|
274 | (4) |
|
|
278 | (1) |
|
Pathways for Coagulation Cascade |
|
|
279 | (1) |
|
Intrinsic Versus Extrinsic Coagulation Pathway |
|
|
279 | (1) |
|
Intrinsic Pathway (Activation of Factor X) |
|
|
279 | (1) |
|
Extrinsic Pathway (Activation of Factor X) |
|
|
279 | (1) |
|
Common Pathway (Formation of Fibrin Clot From Factor X) |
|
|
280 | (1) |
|
|
280 | (1) |
|
Protective Mechanisms Against Thrombosis |
|
|
281 | (1) |
|
|
281 | (1) |
|
|
281 | (1) |
|
Natural Anticoagulant Systems |
|
|
281 | (1) |
|
Therapeutic Anticoagulant Therapy |
|
|
282 | (2) |
|
Tests for Hemostasis and Coagulation |
|
|
284 | (1) |
|
Screening Tests for Disorders of the Hemostatic System |
|
|
284 | (1) |
|
Tests for Platelet Function |
|
|
285 | (1) |
|
Tests for Plasma Coagulation Factors |
|
|
286 | (2) |
|
Performance of Coagulation Assays |
|
|
288 | (3) |
|
Point-of-Care Tests for Coagulation Assays |
|
|
291 | (1) |
|
|
292 | (4) |
|
12 Renal Physiology and Urinalysis |
|
|
296 | (62) |
|
|
298 | (1) |
|
|
298 | (1) |
|
|
298 | (1) |
|
Quality Assessment and Quality Control |
|
|
299 | (1) |
|
Renal Anatomy and Physiology |
|
|
299 | (1) |
|
|
299 | (1) |
|
|
300 | (3) |
|
|
303 | (1) |
|
|
303 | (1) |
|
|
303 | (1) |
|
Identification of a Fluid as Urine |
|
|
304 | (1) |
|
Collection and Preservation of Urine Specimens |
|
|
304 | (1) |
|
|
304 | (1) |
|
Containers for Urine Collection |
|
|
305 | (1) |
|
Urine Volume for Routine Urinalysis |
|
|
306 | (1) |
|
Preservation of Urine Specimens |
|
|
306 | (1) |
|
Labeling and Processing of Urine Specimens |
|
|
307 | (1) |
|
Physical Properties of Urine |
|
|
307 | (1) |
|
|
308 | (1) |
|
|
308 | (1) |
|
|
308 | (1) |
|
|
309 | (1) |
|
|
309 | (1) |
|
Chemical Tests in Routine Urinalysis |
|
|
310 | (1) |
|
|
310 | (3) |
|
|
313 | (3) |
|
Blood (Hemoglobin and Myoglobin) |
|
|
316 | (2) |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
319 | (2) |
|
|
321 | (1) |
|
Bilirubin and Urobilinogen |
|
|
322 | (4) |
|
|
326 | (1) |
|
Microscopic Analysis of Urine Sediment |
|
|
326 | (1) |
|
|
326 | (1) |
|
|
327 | (1) |
|
Techniques for Examination of Urine Sediment |
|
|
327 | (1) |
|
|
328 | (1) |
|
Specimen Preparation (Concentration) |
|
|
329 | (1) |
|
|
329 | (1) |
|
Constituents of Urine Sediment |
|
|
329 | (1) |
|
|
329 | (3) |
|
|
332 | (3) |
|
|
335 | (6) |
|
Crystals and Amorphous Material |
|
|
341 | (6) |
|
Other Cellular Constituents |
|
|
347 | (1) |
|
Contaminants and Artifacts |
|
|
348 | (1) |
|
|
349 | (1) |
|
|
349 | (2) |
|
|
351 | (1) |
|
|
351 | (1) |
|
|
351 | (7) |
|
13 Examination of Body Fluids and Miscellaneous Specimens |
|
|
358 | (26) |
|
|
359 | (1) |
|
|
359 | (1) |
|
Collection of Cerebrospinal Fluid |
|
|
360 | (1) |
|
Routine and Special Examination of Cerebrospinal Fluid |
|
|
361 | (5) |
|
Characteristics of Transudates and Exudates |
|
|
366 | (1) |
|
Collection of Serous Fluids |
|
|
367 | (1) |
|
Routine Examination of Serous Fluids |
|
|
367 | (1) |
|
Serous Fluids: Pericardial, Pleural, and Peritoneal |
|
|
367 | (2) |
|
Description of Specific Serous Fluids |
|
|
369 | (1) |
|
|
370 | (1) |
|
|
370 | (1) |
|
|
370 | (1) |
|
Classification of Synovial Fluid in Joint Disease |
|
|
371 | (1) |
|
Collection of Synovial Fluid |
|
|
371 | (1) |
|
Routine Examination of Synovial Fluid |
|
|
371 | (4) |
|
|
375 | (1) |
|
|
375 | (3) |
|
|
378 | (1) |
|
|
378 | (1) |
|
|
378 | (1) |
|
|
379 | (1) |
|
|
379 | (1) |
|
Automated Platforms In Body Fluid Analysis |
|
|
379 | (1) |
|
|
380 | (4) |
|
14 Introduction to the Principles and Practice of Clinical Chemistry |
|
|
384 | (45) |
|
Glucose and Glucose Metabolism |
|
|
386 | (1) |
|
|
387 | (1) |
|
|
388 | (1) |
|
|
388 | (1) |
|
|
388 | (1) |
|
Gestational Diabetes Mellitus |
|
|
389 | (1) |
|
Other Causes of Hyperglycemia |
|
|
390 | (1) |
|
|
390 | (1) |
|
|
390 | (1) |
|
Collection of Blood Specimens for Glucose |
|
|
391 | (1) |
|
|
391 | (1) |
|
Point-of-Care Testing for Glucose |
|
|
392 | (1) |
|
Methods for Qualitative and Semiquantitative Determination of Glucose |
|
|
392 | (1) |
|
Methods for Quantitative Determination of Glucose |
|
|
392 | (1) |
|
|
393 | (1) |
|
Laboratory Tests for Diabetic Management |
|
|
393 | (1) |
|
|
394 | (1) |
|
|
394 | (1) |
|
|
395 | (1) |
|
Sodium and Potassium in Body Fluids |
|
|
395 | (1) |
|
|
395 | (1) |
|
|
396 | (1) |
|
|
396 | (1) |
|
Special Considerations for Specimens |
|
|
396 | (1) |
|
Methods for Quantitative Measurement |
|
|
397 | (1) |
|
|
398 | (1) |
|
|
398 | (1) |
|
Acid-Base Balance and Blood Gases |
|
|
399 | (1) |
|
|
400 | (1) |
|
|
400 | (2) |
|
|
402 | (1) |
|
Estimated Glomerular Filtration Rate |
|
|
403 | (1) |
|
|
404 | (1) |
|
|
404 | (1) |
|
|
404 | (1) |
|
|
404 | (1) |
|
|
404 | (1) |
|
|
404 | (1) |
|
|
405 | (1) |
|
|
405 | (1) |
|
Secondary Hypertriglyceridemia |
|
|
405 | (1) |
|
|
406 | (1) |
|
Secondary Elevations of Low-Density Lipoproteins |
|
|
407 | (1) |
|
|
407 | (1) |
|
|
407 | (1) |
|
Classifications of Cardiac Biomarkers |
|
|
408 | (1) |
|
Historical Cardiac Biomarkers |
|
|
409 | (1) |
|
Specific Biomarkers of Myocardial Damage |
|
|
409 | (1) |
|
Other Biomarkers-Copeptin |
|
|
410 | (1) |
|
Biomarkers of Coronary Risk |
|
|
410 | (1) |
|
Biomarkers of Congestive Heart Failure |
|
|
411 | (1) |
|
Other Miscellaneous Biomarkers |
|
|
411 | (1) |
|
Liver and Pancreatic Testing |
|
|
411 | (1) |
|
|
411 | (1) |
|
|
412 | (1) |
|
|
413 | (1) |
|
|
413 | (2) |
|
Coagulation: Prothrombin Time |
|
|
415 | (1) |
|
|
415 | (1) |
|
|
415 | (1) |
|
|
415 | (1) |
|
|
416 | (1) |
|
Miscellaneous Enzyme Biomarkers in Malignancies |
|
|
416 | (1) |
|
Miscellaneous Hormone Biomarkers in Malignancies |
|
|
416 | (1) |
|
Therapeutic Drug Monitoring |
|
|
417 | (1) |
|
|
417 | (1) |
|
|
418 | (1) |
|
Automation in Clinical Chemistry |
|
|
418 | (1) |
|
Clinical Chemistry and Immunochemistry Analyzers |
|
|
418 | (3) |
|
|
421 | (8) |
|
15 New Frontiers in Molecular Diagnostics |
|
|
429 | (32) |
|
|
430 | (1) |
|
|
430 | (1) |
|
|
431 | (1) |
|
Forms of Ribonucleic Acid |
|
|
432 | (1) |
|
Deoxyribonucleic Acid Mutations and Polymorphisms |
|
|
432 | (1) |
|
|
433 | (2) |
|
Amplification Techniques in Molecular Biology |
|
|
435 | (1) |
|
|
436 | (1) |
|
Target Amplification Methods |
|
|
436 | (1) |
|
Polymerase Chain Reaction |
|
|
436 | (1) |
|
Real-Time Polymerase Chain Reaction |
|
|
437 | (1) |
|
Restriction Fragment Length Polymorphism |
|
|
437 | (1) |
|
Molecular Analysis of Amplification Products |
|
|
437 | (1) |
|
Deoxyribonucleic Acid Sequencing |
|
|
437 | (1) |
|
Sanger (Chain Termination) Sequencing |
|
|
438 | (1) |
|
Nanoball Deoxyribonucleic Acid Sequencing Technology |
|
|
438 | (1) |
|
|
439 | (1) |
|
|
439 | (1) |
|
Fluorescence In Situ Hybridization |
|
|
440 | (1) |
|
Use of Fluorescence In Situ Hybridization in the Clinical Laboratory |
|
|
441 | (1) |
|
|
441 | (1) |
|
|
441 | (1) |
|
|
441 | (1) |
|
|
442 | (1) |
|
Next-Generation Sequencing Technology or Massively Parallel Sequencing |
|
|
442 | (3) |
|
Target Enrichment Strategies |
|
|
445 | (1) |
|
Steps of Next-Generation Sequencing |
|
|
445 | (1) |
|
Molecular Diagnostic Testing Clinical Applications |
|
|
446 | (1) |
|
|
446 | (1) |
|
Molecular Testing in Viral Diseases |
|
|
446 | (2) |
|
Molecular Testing in Bacterial Diseases |
|
|
448 | (1) |
|
|
448 | (1) |
|
|
448 | (1) |
|
Molecular Diagnostic Testing in Genetic Disorders |
|
|
448 | (2) |
|
|
450 | (1) |
|
|
450 | (1) |
|
Acute Myelogenous Leukemias |
|
|
451 | (2) |
|
|
453 | (1) |
|
|
453 | (1) |
|
Molecular Methods of Testing in Cancer |
|
|
454 | (1) |
|
|
455 | (6) |
|
16 Introduction to Medical Microbiology |
|
|
461 | (64) |
|
Introduction to Microorganisms |
|
|
463 | (1) |
|
Prokaryotic and Eukaryotic Cell Differences |
|
|
464 | (1) |
|
Classification of Microorganisms: Taxonomy |
|
|
464 | (1) |
|
Normal Flora (Microbiota) |
|
|
465 | (1) |
|
Pathogenic Microorganisms |
|
|
466 | (1) |
|
Protection of Laboratory Personnel and Good Laboratory Practices |
|
|
466 | (1) |
|
Classification of Biological Agents Based on Hazard to Personnel |
|
|
466 | (1) |
|
General Safety Practices in the Microbiology Laboratory |
|
|
467 | (1) |
|
Disinfection and Sterilization Techniques |
|
|
468 | (1) |
|
Specimens for Microbiological Examination |
|
|
468 | (1) |
|
Specimen Collection Requirements for Culture |
|
|
469 | (1) |
|
|
469 | (1) |
|
Transport to the Laboratory |
|
|
469 | (1) |
|
Handling and Storing Specimens in the Laboratory |
|
|
469 | (1) |
|
Types of Microbiology Specimens Collected |
|
|
470 | (1) |
|
Basic Equipment and Techniques Used In Microbiology |
|
|
471 | (1) |
|
Inoculating Needle or Loop |
|
|
471 | (1) |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
472 | (2) |
|
Identification of Bacteria |
|
|
474 | (1) |
|
Smear Preparation and Stains Used in Microbiology |
|
|
474 | (6) |
|
|
480 | (1) |
|
|
480 | (1) |
|
Requirements for Bacterial Cultivation |
|
|
481 | (5) |
|
Biochemical or Enzymatic Tests |
|
|
486 | (3) |
|
|
489 | (1) |
|
|
489 | (1) |
|
Methods for Detection of Urinary Tract Infections |
|
|
489 | (2) |
|
|
491 | (1) |
|
|
491 | (1) |
|
Methods for Detection of Group A β-Hemolytic Streptococci |
|
|
491 | (1) |
|
|
492 | (1) |
|
|
493 | (1) |
|
Methods for Detection of Common Genitourinary Tract Infections |
|
|
493 | (1) |
|
|
494 | (1) |
|
|
494 | (1) |
|
|
494 | (1) |
|
|
494 | (1) |
|
|
495 | (1) |
|
Organisms Commonly Isolated from Blood |
|
|
495 | (1) |
|
|
496 | (1) |
|
Examination of Blood Cultures |
|
|
496 | (1) |
|
Other Methods for the Identification of Bacteremia |
|
|
497 | (1) |
|
Wound or Soft Tissue Cultures |
|
|
497 | (1) |
|
Organisms Commonly Isolated From Wounds or Soft Tissue Infections |
|
|
497 | (1) |
|
|
497 | (1) |
|
Culture Media for Wound and Tissue Infections |
|
|
497 | (1) |
|
|
498 | (1) |
|
Antimicrobial Susceptibility Tests |
|
|
498 | (5) |
|
Quality Control in The Microbiology Laboratory |
|
|
503 | (1) |
|
|
503 | (1) |
|
|
503 | (1) |
|
Control of Reagents and Antisera |
|
|
503 | (1) |
|
Control of Antimicrobial Tests |
|
|
503 | (1) |
|
Control of Specimens, Specimen Collection, and Specimen Rejection |
|
|
503 | (1) |
|
|
503 | (1) |
|
|
503 | (1) |
|
|
504 | (1) |
|
Acid-Fast Stain Using Kinyoun Carbolfuchsin Method |
|
|
504 | (1) |
|
Tests for Fungi (Mycology) |
|
|
504 | (1) |
|
|
504 | (1) |
|
Fungi as Source of Infection |
|
|
505 | (1) |
|
Collection of Specimens for Fungal Studies |
|
|
505 | (1) |
|
Methods for Detection of Fungi |
|
|
505 | (3) |
|
Tests for Parasites (Parasitology) |
|
|
508 | (1) |
|
Parasites as Source of Infection |
|
|
508 | (1) |
|
Collection of Specimens for Parasite Identification |
|
|
509 | (1) |
|
Methods for Detection of Parasites |
|
|
510 | (1) |
|
Common Parasites Identified |
|
|
510 | (4) |
|
Tests for Viruses (Virology) |
|
|
514 | (1) |
|
Characteristics of Viruses |
|
|
514 | (1) |
|
Viruses as a Source of Infection |
|
|
514 | (1) |
|
Collection of Specimens for Viral Identification |
|
|
515 | (1) |
|
Methods for Detection of Viruses |
|
|
515 | (2) |
|
|
517 | (1) |
|
|
517 | (1) |
|
Mass Spectrophotometry (MALDI-TOF) |
|
|
517 | (1) |
|
|
518 | (7) |
|
17 Immunology and Serology |
|
|
525 | (45) |
|
Overview of Immunology and Serology |
|
|
527 | (1) |
|
|
528 | (1) |
|
|
528 | (1) |
|
Characteristics of Antibodies |
|
|
528 | (1) |
|
|
529 | (1) |
|
Monoclonal and Polyclonal Antibodies |
|
|
529 | (1) |
|
|
530 | (1) |
|
|
530 | (1) |
|
|
530 | (2) |
|
|
532 | (1) |
|
|
532 | (1) |
|
Body Defenses Against Microbial Disease |
|
|
533 | (1) |
|
|
533 | (1) |
|
|
533 | (1) |
|
Second Line of Defense: Natural Immunity |
|
|
533 | (1) |
|
Third Line of Defense: Acquired or Adaptive Immunity |
|
|
533 | (2) |
|
|
535 | (1) |
|
What Is Hypersensitivity? |
|
|
535 | (1) |
|
Hypersensitivity Reactions |
|
|
535 | (1) |
|
|
536 | (1) |
|
Types of Antigens and Reactions |
|
|
536 | (1) |
|
|
537 | (1) |
|
|
537 | (1) |
|
|
537 | (1) |
|
|
537 | (1) |
|
Cells and Cellular Activities of the Immune System |
|
|
537 | (1) |
|
Role of Granulocytes and Mononuclear Cells: Phagocytosis |
|
|
537 | (1) |
|
Role of Lymphocytes and Plasma Cells |
|
|
538 | (1) |
|
|
538 | (1) |
|
Primary Immunodeficiency Disorders |
|
|
538 | (1) |
|
Secondary Immunodeficiency Disorders |
|
|
539 | (1) |
|
Principles of Immunologic and Serologic Methods |
|
|
539 | (1) |
|
Principles of Agglutination |
|
|
539 | (1) |
|
Microplate Agglutination Reactions |
|
|
540 | (1) |
|
|
540 | (1) |
|
Other Labeling Techniques |
|
|
540 | (1) |
|
|
540 | (2) |
|
|
542 | (1) |
|
|
542 | (1) |
|
Specimens for Serology and Immunology |
|
|
542 | (1) |
|
Testing for Antibody Levels |
|
|
543 | (1) |
|
|
543 | (1) |
|
|
543 | (1) |
|
Immunologic and Serologic Testing for Bacterial and Viral Diseases |
|
|
544 | (1) |
|
COVID-19 (SARS-CoV-2 disease) |
|
|
544 | (3) |
|
|
547 | (1) |
|
|
548 | (1) |
|
Acquired Immunodeficiency Syndrome |
|
|
549 | (2) |
|
|
551 | (3) |
|
|
554 | (2) |
|
|
556 | (1) |
|
|
556 | (2) |
|
Systemic Lupus Erythematosus |
|
|
558 | (2) |
|
|
560 | (1) |
|
|
560 | (1) |
|
Historic Tumor Biomarkers |
|
|
560 | (2) |
|
Categories of Tumor Antigens |
|
|
562 | (1) |
|
|
562 | (1) |
|
Tumor-Associated Antigens |
|
|
562 | (1) |
|
|
562 | (1) |
|
Spontaneous Tumor Antigens |
|
|
562 | (3) |
|
|
565 | (5) |
|
18 Immunohematology and Transfusion Medicine |
|
|
570 | (44) |
|
Overview of Blood Banking |
|
|
572 | (1) |
|
Benefits and Reasons for Transfusion |
|
|
573 | (1) |
|
Whole Blood, Blood Components, and Derivatives for Transfusion |
|
|
573 | (1) |
|
|
573 | (2) |
|
|
575 | (1) |
|
|
575 | (1) |
|
|
575 | (1) |
|
Blood Donation Safety Factors |
|
|
576 | (1) |
|
Blood Donation: Donor Screening, Collection, Storage, and Processing |
|
|
576 | (1) |
|
|
576 | (1) |
|
|
576 | (1) |
|
|
576 | (1) |
|
|
576 | (1) |
|
Problems and Deficiencies |
|
|
577 | (1) |
|
Blood Donation: Donors, Collection, Storage, and Processing |
|
|
577 | (1) |
|
Requirements by Donation Type |
|
|
577 | (1) |
|
Plateletpheresis and Leukapheresis |
|
|
577 | (1) |
|
Donor Selection and Identification |
|
|
577 | (1) |
|
Common Reasons for Donor Rejection |
|
|
577 | (2) |
|
Collection of Red Blood Cells |
|
|
579 | (1) |
|
|
580 | (1) |
|
|
580 | (1) |
|
Other Types of Blood Donations |
|
|
581 | (1) |
|
|
581 | (1) |
|
|
581 | (1) |
|
Antigens and Antibodies in Immunohematology |
|
|
581 | (1) |
|
|
581 | (1) |
|
Inheritance of Red Blood Cell Groups |
|
|
581 | (1) |
|
Isoantibodies and Immune Antibodies |
|
|
582 | (1) |
|
Means of Detecting Antigen--Antibody Reactions |
|
|
582 | (3) |
|
|
585 | (1) |
|
ABO Red Blood Cell Group System |
|
|
586 | (1) |
|
|
586 | (1) |
|
|
587 | (1) |
|
|
587 | (1) |
|
Isoantibodies of ABO System |
|
|
588 | (2) |
|
Universal Donors and Recipients |
|
|
590 | (1) |
|
Rh Red Blood Cell Group System |
|
|
591 | (1) |
|
|
591 | (1) |
|
Definition of Rh Antigens and Inheritance |
|
|
591 | (1) |
|
Characteristics of Rh Antigens |
|
|
592 | (1) |
|
Characteristics of Rh Antibodies |
|
|
592 | (1) |
|
Types of Rh Typing Reagents (Antisera) |
|
|
592 | (1) |
|
Typing Blood for Transfusion |
|
|
593 | (1) |
|
Other Blood Group Systems |
|
|
594 | (1) |
|
Antihuman Globulin Reaction |
|
|
594 | (1) |
|
Preparation and Nature of Antihuman Globulin Reagent |
|
|
595 | (1) |
|
Antihuman Globulin Test Procedures |
|
|
595 | (1) |
|
Compatibility Testing: Definition and General Considerations |
|
|
595 | (1) |
|
ABO and Rh Typing of Donor and Recipient |
|
|
596 | (1) |
|
Clinically Significant Antibody Screening and Identification |
|
|
596 | (1) |
|
|
597 | (2) |
|
Molecular-Based Transfusion Testing |
|
|
599 | (1) |
|
Benefits and Applications |
|
|
599 | (1) |
|
Molecular-Based Testing Methods |
|
|
600 | (3) |
|
Adverse Effects of Transfusion |
|
|
603 | (1) |
|
Immediate Immunologic Adverse Reactions |
|
|
603 | (1) |
|
Immediate Nonimmunologic Adverse Reactions |
|
|
604 | (1) |
|
Other Severe Adverse Reactions |
|
|
604 | (1) |
|
Hemolytic Disease of the Fetus and Newborn |
|
|
604 | (1) |
|
|
604 | (1) |
|
|
605 | (1) |
|
|
605 | (1) |
|
Routine Laboratory Prenatal and Postnatal Testing |
|
|
605 | (1) |
|
|
606 | (1) |
|
Prevention of Rh Immunization |
|
|
606 | (2) |
|
Automated Testing Technology and Systems |
|
|
608 | (1) |
|
|
608 | (1) |
|
Automated Solid-Phase Red Cell Adherence Assays |
|
|
608 | (1) |
|
|
609 | (5) |
Appendix A Answers to Review Questions and Case Studies |
|
614 | (9) |
Appendix B AMA Recognized Disease/Organ Panels |
|
623 | (3) |
Appendix C Periodic Table |
|
626 | (1) |
Appendix D Overview of COVID-19 |
|
627 | (3) |
Appendix E Molecular Testing Methods |
|
630 | (3) |
Appendix F Quick Calculations and Adult Reference Values |
|
633 | (5) |
Glossary |
|
638 | (17) |
Index |
|
655 | |